All data are based on the daily closing price as of July 17, 2024
h

Hanmi Pharmaceutical

008930.KO
23.62 USD
0.24
+1.03%

Overview

Last close
23.62 usd
Market cap
1.56B usd
52 week high
41.97 usd
52 week low
22.22 usd
Target price
23.5 usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
1.8992
Price/Book Value
3.0095
Enterprise Value
1.77B usd
EV/Revenue
2.0428
EV/EBITDA
17.059

Key financials

Revenue TTM
926.65M usd
Gross Profit TTM
95.15M usd
EBITDA TTM
47.06M usd
Earnings per Share
N/A usd
Dividend
0.15 usd
Total assets
930.56M usd
Net debt
N/A usd

About

Hanmi Science Co., Ltd., through its subsidiaries, manufactures and sells pharmaceutical products in Korea and internationally. It develops drugs in the areas of diabetes and anti-cancer, as well as children's and adult's bowel preparation and cold medicines, and cephalosporin antibiotics. The company also offers general foods, health functional foods, soy milk, and medical equipment. In addition, it offers automated drug management systems. The company sells its products through online and offline pharmacies. The company was formerly known as Hanmi Holdings Co., Ltd. and changed its name to Hanmi Science Co., Ltd. in March 2012. Hanmi Science Co., Ltd. was founded in 1973 and is headquartered in Seoul, South Korea.
  • Symbol
    008930.KO
  • Exchange
    KO
  • Isin
    KR7008930000
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Medical Distribution
  • CEO
    Mr. Lim Chong-Yoon
  • Headquarter
    Seoul
  • Web site
    https://www.hanmiscience.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top